The FTC's first report drew a strong response from the PBM sector, with lawsuits filed in both directions. The FTC has accused the big three of operating a "perverse drug rebate system," while the ...

The CEOs of CVS Health and UnitedHealth Group praised pharmacy benefit managers and promised transparency during investor ...

The U.S. Federal Trade Commission’s lawsuit against major pharmacy benefit managers, including UnitedHealth Group’s Optum, ...

Federal Trade Commission Chair Andrew Ferguson has reversed course on his decision to recuse himself from the agency's legal ...

President Donald Trump’s firing this week of two Democratic members of the Federal Trade Commission calls into question how the agency’s lawsuit against the country’s three largest pharmacy middlemen ...

Federal Trade Commission Chairman Andrew Ferguson said he wants to bring back the agency’s case against pharmacy benefit ...

The Federal Trade Commission is pausing its litigation against ... However, Rhyee noted that PBM reform could still be included in the reconciliation bill being hammered out in Congress.

Members voted to approve a bill that calls for the FTC to explain how to increase pharmaceutical supply chain competition and ...

The FTC lawsuit accuses the PBMs of unfairly limiting access to insulin drugs with lower list prices and steering diabetes ...